Work

A Phase 1b Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Stem Cell Transplantation

Year: 2022

Type: article

Source: Blood

DOI: 10.1182/blood-2022-162386

Authors: Doris M Ponce, Jonathan U Peled, Bindu Tejura, Christopher Ford, Marcel R M van den Brink, Mary Jane Lombardo, Satyajit Kosuri, Nandita Khera, Zachariah Defilipp, Lisa von Moltke

Institutions: Memorial Sloan Kettering Cancer Center, Seres Therapeutics (United States), University of Chicago Medical Center, Mayo Clinic in Arizona, Mayo Clinic Hospital, Harvard University, Massachusetts General Hospital

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310104784

FWCI: 0.082

Cites:

Cited by: 1

Related to: 10